February 27, 2026 · Form 4 insider transaction
Leupin Nicolas sold 1,029 shares of NovoCure Limited at $13.66 per share, a transaction worth $14.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.; This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price.